2Rosenzweig P, Caplain H, Chaufour S, et al. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine,loratadine and placebo in healthy volunteers [J]. Br J Clin Pharmacol, 1995, 40(5): 459-465.
4Michel L, Murrieta-Aguttes M, Jean-Louis F, et al. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine [J]. Ann Allergy Asthma Immunol, 2000, 85(1): 64-69.
2[1]Benavides J, SchoemakerH, Dana C, et al. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent[J] Arzneimittelforschung, 1995, 45(5): 551-558.
4[3]Kontou-Fili K. Clinical advantages of dual activity in urticaria[J] .Allergy, 2000, (Suppl 64): 28-33.
5[4]Lee EE, Maibach HI. Treatment of urticaria. An evidence-based evaluation of antihistamines[J] . Am J Clin Dermatol 2001, 2 (1):27-32.
6[1]Prakash A, Lamb HM.. Mizolastine: A review of its use in allergic rhinitis and chronic idiopathic urticaria[J]. Biodrug,1998, 10(1):42-59.
7[2]Scadding GK, Tasman AJ, Murrieta-Aguttes M, et al. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis[J]. J Int Med Res, 1999, 27(6):273-285.
8[3]Wedi B, Novacovic V,Koemer M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of antiinflammatory drugs[J]. J Allergy Clin Immunol, 2000,105(3):552-560.
9[4]Pichat P, Angel I, Arbilla S. Anti-inflammatory properties of Mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat [J]. Arzneim-Forsch / Drug Res .1998, 48(1):173-178.
10[5]Simons FER, Simons LJ. Clinical pharmacology of new histamine H1 receptor antagonists[J]. Clin Pharmacokinet, 1999, 36(5): 329-352.
